Barclays’s EnteroMedics ETRM Stock Holding History
Bought
Maintained
Sold
Other funds holding ETRM
Barclays's ETRM Position: Q4 2017 in Review
Barclays sold out of EnteroMedics (ETRM) in Q4 2017, closing a stake of 40 shares.
Barclays first reported a position in ETRM in Q2 2013 and held it in 3 quarters. The position peaked at $106K in Q2 2013. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.
- Barclays reported no remaining EnteroMedics position as of Q4 2017 after selling out during the quarter.
- Barclays sold 40 EnteroMedics shares in Q4 2017.
- Barclays first reported a position in EnteroMedics in Q2 2013 and held it in 3 quarters.
- Barclays's EnteroMedics position peaked at $106K in Q2 2013.
- 1 fund tracked by Wall St. Rank held EnteroMedics as of Q4 2017.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.